Genome medicine: gene therapy for the millennium, 30 September-3 October 2001, Rome, Italy.
The recent surge of DNA sequence information resulting from the efforts of agencies interested in deciphering the human genetic code has facilitated technological developments that have been critical in the identification of genes associated with numerous disease pathologies. In addition, these efforts have opened the door to the opportunity to develop novel genetic therapies to treat a broad range of inherited disorders. Through a joint effort by the University of Vermont, the University of Rome, Tor Vergata, University of Rome, La Sapienza, and the CSS Mendel Institute, Rome, an international meeting, 'Genome Medicine: Gene Therapy for the Millennium' was organized. This meeting provided a forum for the discussion of scientific and clinical advances stimulated by the explosion of sequence information generated by the Human Genome Project and the implications these advances have for gene therapy. The meeting had six sessions that focused on the functional evaluation of specific genes via biochemical analysis and through animal models, the development of novel therapeutic strategies involving gene targeting, artificial chromsomes, DNA delivery systems and non-embryonic stem cells, and on the ethical and social implications of these advances.
Gruenert
D C
DC
Human Molecular Genetics, Department of Medicine, University of Vermont, Burlington, VT 05405, USA.
Novelli
G
G
Dallapiccola
B
B
Colosimo
A
A
D005544:Forecasting; D030342:Genetic Diseases, Inborn / Q000628:therapy*; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors; D018380:Hematopoietic Stem Cell Transplantation; D016045:Human Genome Project; D006801:Humans; D007391:International Cooperation; D015202:Protein Engineering